Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

NCT02647515 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Glaucoma, Neovascular

Interventions

DRUG: ranibizumab

Sponsor

Ruijin Hospital

Collaborators

[object Object]